
### [MONDO:0002245](http://purl.obolibrary.org/obo/MONDO_0002245)
**Label:** blood platelet disease

**Subclasses:** [MONDO:0011173](http://purl.obolibrary.org/obo/MONDO_0011173) (thrombocythemia 2), [MONDO:0013794](http://purl.obolibrary.org/obo/MONDO_0013794) (thrombocythemia 3), [MONDO:0010308](http://purl.obolibrary.org/obo/MONDO_0010308) (thrombocytopenia, X-linked, with or without dyserythropoietic anemia), [MONDO:0009276](http://purl.obolibrary.org/obo/MONDO_0009276) (Bernard-Soulier syndrome), [MONDO:0007686](http://purl.obolibrary.org/obo/MONDO_0007686) (gray platelet syndrome), [MONDO:0008552](http://purl.obolibrary.org/obo/MONDO_0008552) (platelet-type bleeding disorder 16), [MONDO:0019111](http://purl.obolibrary.org/obo/MONDO_0019111) (familial thrombocytosis), [MONDO:0008554](http://purl.obolibrary.org/obo/MONDO_0008554) (thrombocythemia 1), [MONDO:0015372](http://purl.obolibrary.org/obo/MONDO_0015372) (autosomal dominant macrothrombocytopenia), [MONDO:0015912](http://purl.obolibrary.org/obo/MONDO_0015912) (MYH-9 related disease), 

**Corr. equiv. classes:** [OMIM:139090](http://purl.obolibrary.org/obo/OMIM_139090), [OMIM:614521](http://purl.obolibrary.org/obo/OMIM_614521), [Orphanet:182050](http://www.orpha.net/ORDO/Orphanet_182050), [OMIM:187950](http://purl.obolibrary.org/obo/OMIM_187950), [OMIM:231200](http://purl.obolibrary.org/obo/OMIM_231200), [Orphanet:274](http://www.orpha.net/ORDO/Orphanet_274), [OMIM:601977](http://purl.obolibrary.org/obo/OMIM_601977), [OMIM:300367](http://purl.obolibrary.org/obo/OMIM_300367), [Orphanet:71493](http://www.orpha.net/ORDO/Orphanet_71493), [OMIM:187800](http://purl.obolibrary.org/obo/OMIM_187800), [Orphanet:140957](http://www.orpha.net/ORDO/Orphanet_140957), [Orphanet:721](http://www.orpha.net/ORDO/Orphanet_721), 

**Class expressions from DL-Learner:**

- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and (not ([HP:0004845](http://purl.obolibrary.org/obo/HP_0004845) (Acute monocytic leukemia))) 62.50%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and (not ([HP:0004808](http://purl.obolibrary.org/obo/HP_0004808) (Acute myeloid leukemia))) 62.50%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and (not ([HP:0002488](http://purl.obolibrary.org/obo/HP_0002488) (Acute leukemia))) 62.50%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 62.50%
- [HP:0030402](http://purl.obolibrary.org/obo/HP_0030402) (Abnormal platelet aggregation) 55.80%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) 55.80%
- [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) and [HP:0030402](http://purl.obolibrary.org/obo/HP_0030402) (Abnormal platelet aggregation) 55.80%
- [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0030402](http://purl.obolibrary.org/obo/HP_0030402) (Abnormal platelet aggregation) 55.80%
- [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0030402](http://purl.obolibrary.org/obo/HP_0030402) (Abnormal platelet aggregation) 55.80%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and [HP:0011873](http://purl.obolibrary.org/obo/HP_0011873) (Abnormal platelet count) 55.80%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) 55.80%
- [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 55.80%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0030402](http://purl.obolibrary.org/obo/HP_0030402) (Abnormal platelet aggregation) 55.80%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0003540](http://purl.obolibrary.org/obo/HP_0003540) (Impaired platelet aggregation) 55.80%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) and [HP:0030402](http://purl.obolibrary.org/obo/HP_0030402) (Abnormal platelet aggregation) 55.80%


